Novel Technology Commercialization

Blazing a trail isn’t easy, but that’s not why you’re doing it. Navigating strategy for novel technologies and creating new, uncharted markets requires creativity, innovation, and experience. We’re here to help.

Our Experts

Stephane Budel

Miguel Edwards

Andrew Aijian

Carl Schoellhammer

Schedule a Call

Related Client Results

All Client Results

Financial Services

High-Level Commercial Due Diligence in Digital Pathology

An early-stage venture firm requested a high-level commercial due diligence of a potential investment

View

Due Diligence

Pharma & Biotech

Cell Therapy Market Trends and Revenue Forecast

DeciBio conducted financial projections, valuation, and assisted with messaging to aid client's public listing to NASDAQ

View

Revenue Projection

NIPT Menu and Technology Offerings

A leading diagnostics player asked DeciBio to characterize the evolving NIPT market to help inform strategic positioning regarding menu offerings and technological approach

View

Voice-of-Customer Research

Clinical Diagnostics

Diagnostic Advisory Board

A diagnostics company requested DeciBio to help an advisory board (ad board) to understand how to position its relatively new somatic oncology genomics profiling product in an already competitive market

View

Voice-of-Customer Research

KOL Identification

Pharma & Biotech

Global Companion Diagnostic Guideline Mapping and Strategy

A large pharma new to precision oncology wanted to understand the processes and requirements to ensure that their novel CDx was included into diagnostic guidelines globally

View

Biomarker and Diagnostics Strategy

Go-to-Market Strategy

Pharma & Biotech

Cell and Gene Therapy Services Landscape Assessment

A top-10 scientific service provider wanted to quantify the size of the CGT services market and understand trends within

View

No items found.

Precision Medicine is evolving at a rapid pace

Discover how we can help

Get in Touch